广地龙特异性引物序列的设计及其混伪品的鉴别
The Design of Specific Primers of Pheretima aspergillum<\i> and the Identification of Adulterants
-
摘要: 目的 通过设计特异性引物来鉴定广地龙及其混伪品。方法 提取广地龙及其混伪品的DNA。利用通用引物COⅠ序列对广地龙及其混伪品进行PCR扩增,并对扩增产物进行双向测序。通过比对广地龙及其混伪品的COⅠ序列,找出广地龙的变异位点,设计出广地龙的特异性引物,用于广地龙及其混伪品的鉴定。对PCR反应条件退火温度、循环次数、DNA模板量和Taq酶用量进行适应性考察。结果 COⅠ序列不存在特异性,不同物种、不同品种的动物药均可扩增出750 bp大小的片段,无法鉴定广地龙及其混伪品。通过比对广地龙及其混伪品的COⅠ序列,设计出广地龙的特异性引物PA-f/PA-r。在建立的PCR反应体系中,只有广地龙可以获得574 bp的基因片段,其他混伪品未扩增出相应条带。结论 设计的广地龙特异性引物可以准确、成功鉴别广地龙,与其他混伪品区分,为广地龙的品种鉴别提供了有效的方法。Abstract: OBJECTIVE The specific primers were designed to identify Pheretima aspergillum and its adulterants. METHODS The DNA of Pheretima aspergillum and its adulterants were extracted and amplified using the COⅠsequences as primers. The amplification products were sequenced afterwards. By comparing the COⅠsequences of Pheretima aspergillum with its adulterants, the variation sites were found in Pheretima aspergillum and the specific primers were designed to identify Pheretima aspergillum and its adulterants. PCR reaction system was optimized. RESULTS 750 bp fragments could be detected in the products of other animal medicinal materials using the COⅠsequences as primers, which meant the primers were not specific enough to distinguish the Pheretima aspergillum from its adulterants. Based on the COⅠsequences of amplification products, the specific primers PA-f/PA-r were designed. Through the established PCR reaction system, 574 bp fragments were amplified from DNA templates of Pheretima aspergillum. All the adulterants had no bands. CONCLUSION The designed primers sequences could accurately and successfully distinguish the Pheretima aspergillum from its adulterants, providing an effective method for the identification of Pheretima aspergillum.
-
Key words:
- Pheretima aspergillum<\i> /
- DNA /
- specific primer /
- identification /
- adulterants
-
[1] 国家药典委员会.中华人民共和国药典:一部[M]. 北京:中国医药科技出版社,2015:122. [2] 孙洁,魏劭恒,毛润乾,等.广地龙古今入药品种对比研究[J].中药材,2018,41(6):1312-1316. [3] 李承德,毛淑梅,康白,等.地龙降压蛋白对血管紧张素Ⅱ、醛固酮、6-酮-前列腺素-F1a含量的影响[J].中医药临床杂志,2008,20(5):458-459. [4] 唐秋凤,刘顺会,徐晓鹏,等.地龙对哮喘小鼠气道重塑的作用[J].广东药学院学报,2013,29(35):547-551. [5] 张兰娥,康白,李承德,等.地龙耐热蛋白降压作用的研究[J].实用医学杂志,2008,24(11):1886-1887. [6] 马远娜.蚯蚓活性蛋白抗结肠癌DLD-1细胞作用机制的研究[D].济南:山东大学,2014. [7] 赵锐,纪建国,童元鹏,等.赤子爱胜蚓(Eisenia foetida)中抗肿瘤与纤溶酶原激酶活性蛋白质的分离与鉴定[J].生物化学与生物物理学报,2002(5):576-582. [8] 陈学东,王若光,尤昭玲,等.地龙抗鼻咽癌蛋白组分的蛋白芯片检测[J].中国耳鼻咽喉颅底外科杂志,2008,14(2):96-97,102. [9] 郭建,高福云,靳耀英,等.地龙活性蛋白对免疫造血功能的影响及其抗肿瘤作用[J].中华中医药杂志,2009,24(5):670-672. [10] 杨新.地龙抗凝血活性物质研究[D].武汉:江汉大学,2017. [11] 唐鼎,凃乾,李娟,等.药用地龙的药理作用和临床研究进展[J].中国药师,2015,18(6):1016-1019. [12] 郭征兵.中药地龙的药理作用及活性成分分析[J].当代医学,2017,23(19):199-200. [13] 王春玲.中药地龙的活性成分与药理作用研究[J].亚太传统医药,2015,11(7):53-54. [14] 陈洪,陆亚琴,刘顺英,等.地龙2号对肝纤维化模型大鼠肝星状细胞活化及TGF-β1蛋白表达的影响[J].江苏中医药,2005,37(1):50-52. [15] 格小光,蒋超,田娜,等.基于DNA测序技术的市售地龙类药材基原调查与考证研究[J].中国现代中药,2019,21(9):1206-1214. [16] 陈伟韬,毕晓黎,李养学,等.广地龙药材、汤剂及配方颗粒的元素分析[J].中国药师,2019,22(11):2102-2105. [17] WEITSCHEK E,FISCON G,FELICI G.Supervised DNA Barcodes species classification:analysis,comparisons and results[J].BioData Min,2014,7(1):4. [18] KHEDKAR GD,JAMDADE R,NAIK S,et al.DNA barcodes for the fishes of the Narmada,one of India's longest Rivers[J].PLoS One,2014,9(7):e101460. [19] 庞中化,王志刚,成小兰,等.全蝎DNA条形码分子鉴定研究[J].中国现代中药,2019,21(9):1192-1196,1205. [20] 贾静,石林春,姚辉,等.市售动物药材僵蚕的DNA条形码鉴定研究[J].药学学报,2016,51(11):1784-1790. [21] 赵玉洋,周骏辉,袁媛,等.麝香的微型DNA条形码鉴别方法研究[J].中国现代中药,2019,21(9):1186-1191. [22] 刘富艳,金艳,袁媛,等.多重位点特异性PCR鉴别海龙及其混伪品[J].中国实验方剂学杂志,2018,24(15):57-64. [23] 陈维明,马梅,龚玲,等.广地龙特异性PCR分子鉴定[J].广州中医药大学学报,2015,32(3):499-503,507. [24] 田娜,魏艺聪,袁媛,等.地龙的多重位点特异性PCR鉴别[J].中国实验方剂学杂志,2019,25(17):124-129.
点击查看大图
计量
- 文章访问数: 1564
- HTML全文浏览量: 15
- PDF下载量: 348
- 被引次数: 0